Romans 12:19
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
..mine got in the way of 2 big wins.. then I went to et09de I remember him arguing with me about AMZN at 15.oo .. who gonna buy online that's crazy he said.. I had enough to buy 2000 shares.. but didn't ugH !
..he was working for Lightwave during..
The Clay trader death blow.. Kung Fuey :)
$SBFM (COVID-19 and Vitamin D) SUNSHINE BIOPHARMA FILES A PATENT APPLICATION FOR A NEW CORONAVIRUS COVID-19 TREATMENT
Montreal, Canada – (ACCESSWIRE) – Sunshine Biopharma Inc. (OTC Pink Sheets: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of aggressive forms of cancer today announced that it has filed a patent application in the United States for a new treatment for Coronavirus infections, including COVID-19.
Sunshine’s patent application covers composition subject matter pertaining to small molecules for inhibition of the main Coronavirus protease (Mpro), an enzyme that is essential for viral replication. The small molecules covered by the patent application were computer modelled and designed by Dr. Steve N. Slilaty, CEO of Sunshine Biopharma.
The patent application has a priority date of May 22, 2020.
“The causative agent of the current COVID-19 global pandemic is Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), one of several strains of Coronavirus capable of infecting humans and causing serious illness.
SARS-CoV-2 produces several functional proteins in infected human cells by cleaving them from two overlapping viral ‘polyproteins,’ pp1a and pp1ab. One of these functional proteins is a cysteine protease referred to as the main protease (Mpro, also called 3CLpro and nsp5).
Mpro cleaves the viral ‘polyproteins’ at a number of specific sites thereby generating a multi-subunit protein complex termed ‘viral replicase-transcriptase’. Because of its functional indispensability in viral replication, Mpro is an attractive drug target for the development of a treatment for COVID-19 and other Coronavirus infections,” said Dr. Slilaty.
https://www.sunshinebiopharma.com/sunshine-biopharma-files-a-patent-application-for-a-new-coronavirus-covid-19-treatment/
------------
About Essential Calcium Vitamin DTM --- Vitamin D ---
Sunshine Biopharma Receives Health Canada Approval for Essential Calcium-Vitamin DTM Supplement
Montreal, Quebec, Canada – (ACCESSWIRE) – Sunshine Biopharma, Inc. (OTC Markets: “SBFM”) today announced that it has received Health Canada approval for Essential CalciumVitamin DTM supplement, the second in a line of Essential Micronutrients Products that the Company is planning to launch. Health Canada issued NPN 80093432 through which it authorized Sunshine Biopharma to manufacture and sell a Calcium-Vitamin D supplement under the brand name Essential Calcium-Vitamin .
Essential Calcium-Vitamin DTM is a dietary supplement tablet that contains a balanced formula of Calcium and Vitamin D complex.
Vitamin D plays a major role in multiple biological functions, including regulating the concentration of calcium and phosphate, and promoting the healthy growth and remodeling of bone.
In addition, Vitamin D is involved in cell growth, neuromuscular and immune functions, and reduction of inflammation. Sunshine Biopharma anticipates that Essential Calcium-Vitamin DTM will be available on Amazon.ca in January 2020.
The Company’s first Essential Micronutrients Product, Essential 9TM , launched earlier this year is currently available in Canada on Amazon.ca and in the US on Amazon.com.
About Essential Calcium Vitamin DTM
Vitamin D is a group of steroid-like molecules responsible for increasing intestinal absorption of calcium, magnesium, and phosphate. They are also involved in multiple other biological
functions, including promoting the healthy growth and remodeling of bone, cell growth, neuromuscular and immune functions, and reduction of inflammation.
The most important compounds in this group are Vitamin D2 (ergocalciferol) and Vitamin D3 (cholecalciferol).
Sunshine Biopharma’s Essential Calcium-Vitamin DTM tablets contain both of these compounds as well as Calcium for optimum health benefits.
About Essential 9TM - Essential Amino Acids are 9 out of the 20 amino acids required for protein synthesis.
Proteins are involved in all body functions – From the musculature and immune system to hormones and neurotransmitters.
Like vitamins, Essential Amino Acids cannot be made by the human body and must be obtained through diet. Deficiency in one or more of the 9 Essential Amino Acids can lead to loss of muscle mass, fatigue, weight gain and reduced ability to build muscle mass in athletes.
Sunshine Biopharma’s Essential 9TM provides all 9 Essential Amino Acids in freeform and in the proportions recommended by Health Canada. Essential 9TM is suitable for everyone: vegans, athletes, seniors, dieters.
Essential 9tm is currently available on Amazon.ca and Amazon.com
https://www.sunshinebiopharma.com/sunshine-biopharma-receives-health-canada-approval-for-essential-calcium-vitamin-dtm-supplement/
..u r brutal !! ;)
$SBFM #1 Most Read Boards Last 24 Hours Sunshine Biopharma 103,689 reads
$GRLB (Industry Related) The Global CBD Oil Market Revenue is Predicted to Rise at a 24.3% CAGR Between 2020 and 2025, From $1,735.1 Million in 2019
PRESS RELEASE PR Newswire Jul. 16, 2020, 02:10 PM
NEW YORK, July 16, 2020 /PRNewswire/ --
In numerous countries, starting with the U.S. and Canada, cannabis is being legalized for medical, recreational, and research uses.
Following them, the U.K., Japan, Norway, Thailand, South Korea, Spain, Mexico, South Africa, and Brazil have also given the stamp of approval on the cultivation of marijuana and hemp, extraction of cannabidiol and usage of the chemical in various end products.
https://markets.businessinsider.com/news/stocks/the-global-cbd-oil-market-revenue-is-predicted-to-rise-at-a-24-3-cagr-between-2020-and-2025-from-1-735-1-million-in-2019-1029401282#
---------
North America is dominating the CBD Beverages Market
North America is expected the major share of the global CBD Beverages market. The CBD drinks market in the U.S. will be worth USD 260 million by the year 2022, while the combined value of CBD and THC-infused beverages will reach USD 1.4 billion by 2024. By 2029, the global cannabis market could be as big as $130 billion, with CBD beverages contributing a significant portion.
The kombucha craze in America surged in 2016. The tea had an estimated 1.06 billion dollar global market value. In China, a country responsible for producing more than half of the cannabis in the world, most people likely have never heard of it.
Europe is anticipated to hold the second position in the global cannabis beverages market in the future, owing to the rising investment for cannabis beverages and growing awareness.
Rising Awareness of the health benefits expected to grow CBD Beverages market.
The growth is CBD Beverages is primarily driven by an increasing demand for functional beverages made with healthy, natural ingredients and increasing public awareness of the health and wellness benefits of CBD. Combined with the advances in CBD manufacturing technology, there are already many different companies offering CBD-infused drinks in the United States and other countries.
For example, the popular tea company Buddha Teas offers four varieties of CBD tea infused with chamomile, match, and other ingredients.
According to Zenith Global, the U.S. CBD-filled drinks market will reach an estimated USD 1.4 billion by 2023, making it one of the fastest-growing segments in the overall industry.
Rising awareness of consumers on the wellness of the products and a growing number of health-conscious consumers is another factor driving the growth of CBD beverage market.
Additionally, as the amusing market continues to expand, consumers are also experiencing an influx of new products. Aside from traditional cannabis flower, consumers can now choose from a variety of products at dispensaries and trade stores. Currently, cannabis-based concentrates, extracts, and edibles are becoming highly popular among consumers.
It is expected that U.S. consumer sales of cannabidiol usually abbreviated as CBD will reach around 1.8 billion U.S. dollars by 2022. However, regulation and compliance on the use of CBD in the food and beverage industry have the potential to hampers the growth of the market.
The market is expected to cabinet significant growth in the forecast period due to rising adoption of natural products over pharmaceutical products is an opportunity for this market.
https://www.marketwatch.com/press-release/what-is-trending-in-cbd-beverages-market-what-are-the-strategies-to-boost-business-in-near-years-2020-07-07
..lots of good info posts !! Thanks
..had 2 add myself ;) The Future is Here !!
$SBFM another MIST in the making..
$SBFM #1 Sunshine Biopharma Inc. 8,168 reads last hour
#3 Sunshine Biopharma Inc. 54,831 reads last 24 hours
$SBFM - Expect the Unexpected -
$SBFM - Expect the Unexpected -
..didn't notice before but since I bought in have been seeing AI displayed as the next big thing in investor web ads.
$SBFM (COVID-19 and Vitamin D) SUNSHINE BIOPHARMA FILES A PATENT APPLICATION FOR A NEW CORONAVIRUS COVID-19 TREATMENT
Montreal, Canada – (ACCESSWIRE) – Sunshine Biopharma Inc. (OTC Pink Sheets: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of aggressive forms of cancer today announced that it has filed a patent application in the United States for a new treatment for Coronavirus infections, including COVID-19.
Sunshine’s patent application covers composition subject matter pertaining to small molecules for inhibition of the main Coronavirus protease (Mpro), an enzyme that is essential for viral replication. The small molecules covered by the patent application were computer modelled and designed by Dr. Steve N. Slilaty, CEO of Sunshine Biopharma.
The patent application has a priority date of May 22, 2020.
“The causative agent of the current COVID-19 global pandemic is Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), one of several strains of Coronavirus capable of infecting humans and causing serious illness.
SARS-CoV-2 produces several functional proteins in infected human cells by cleaving them from two overlapping viral ‘polyproteins,’ pp1a and pp1ab. One of these functional proteins is a cysteine protease referred to as the main protease (Mpro, also called 3CLpro and nsp5).
Mpro cleaves the viral ‘polyproteins’ at a number of specific sites thereby generating a multi-subunit protein complex termed ‘viral replicase-transcriptase’. Because of its functional indispensability in viral replication, Mpro is an attractive drug target for the development of a treatment for COVID-19 and other Coronavirus infections,” said Dr. Slilaty.
https://www.sunshinebiopharma.com/sunshine-biopharma-files-a-patent-application-for-a-new-coronavirus-covid-19-treatment/
------------
About Essential Calcium Vitamin DTM --- Vitamin D ---
Sunshine Biopharma Receives Health Canada Approval for Essential Calcium-Vitamin DTM Supplement
Montreal, Quebec, Canada – (ACCESSWIRE) – Sunshine Biopharma, Inc. (OTC Markets: “SBFM”) today announced that it has received Health Canada approval for Essential CalciumVitamin DTM supplement, the second in a line of Essential Micronutrients Products that the Company is planning to launch. Health Canada issued NPN 80093432 through which it authorized Sunshine Biopharma to manufacture and sell a Calcium-Vitamin D supplement under the brand name Essential Calcium-Vitamin .
Essential Calcium-Vitamin DTM is a dietary supplement tablet that contains a balanced formula of Calcium and Vitamin D complex.
Vitamin D plays a major role in multiple biological functions, including regulating the concentration of calcium and phosphate, and promoting the healthy growth and remodeling of bone.
In addition, Vitamin D is involved in cell growth, neuromuscular and immune functions, and reduction of inflammation. Sunshine Biopharma anticipates that Essential Calcium-Vitamin DTM will be available on Amazon.ca in January 2020.
The Company’s first Essential Micronutrients Product, Essential 9TM , launched earlier this year is currently available in Canada on Amazon.ca and in the US on Amazon.com.
About Essential Calcium Vitamin DTM
Vitamin D is a group of steroid-like molecules responsible for increasing intestinal absorption of calcium, magnesium, and phosphate. They are also involved in multiple other biological
functions, including promoting the healthy growth and remodeling of bone, cell growth, neuromuscular and immune functions, and reduction of inflammation.
The most important compounds in this group are Vitamin D2 (ergocalciferol) and Vitamin D3 (cholecalciferol).
Sunshine Biopharma’s Essential Calcium-Vitamin DTM tablets contain both of these compounds as well as Calcium for optimum health benefits.
About Essential 9TM - Essential Amino Acids are 9 out of the 20 amino acids required for protein synthesis.
Proteins are involved in all body functions – From the musculature and immune system to hormones and neurotransmitters.
Like vitamins, Essential Amino Acids cannot be made by the human body and must be obtained through diet. Deficiency in one or more of the 9 Essential Amino Acids can lead to loss of muscle mass, fatigue, weight gain and reduced ability to build muscle mass in athletes.
Sunshine Biopharma’s Essential 9TM provides all 9 Essential Amino Acids in freeform and in the proportions recommended by Health Canada. Essential 9TM is suitable for everyone: vegans, athletes, seniors, dieters.
Essential 9tm is currently available on Amazon.ca and Amazon.com
https://www.sunshinebiopharma.com/sunshine-biopharma-receives-health-canada-approval-for-essential-calcium-vitamin-dtm-supplement/
$SBFM (COVID-19 and Vitamin D) SUNSHINE BIOPHARMA FILES A PATENT APPLICATION FOR A NEW CORONAVIRUS COVID-19 TREATMENT
Montreal, Canada – (ACCESSWIRE) – Sunshine Biopharma Inc. (OTC Pink Sheets: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of aggressive forms of cancer today announced that it has filed a patent application in the United States for a new treatment for Coronavirus infections, including COVID-19.
Sunshine’s patent application covers composition subject matter pertaining to small molecules for inhibition of the main Coronavirus protease (Mpro), an enzyme that is essential for viral replication. The small molecules covered by the patent application were computer modelled and designed by Dr. Steve N. Slilaty, CEO of Sunshine Biopharma.
The patent application has a priority date of May 22, 2020.
“The causative agent of the current COVID-19 global pandemic is Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), one of several strains of Coronavirus capable of infecting humans and causing serious illness.
SARS-CoV-2 produces several functional proteins in infected human cells by cleaving them from two overlapping viral ‘polyproteins,’ pp1a and pp1ab. One of these functional proteins is a cysteine protease referred to as the main protease (Mpro, also called 3CLpro and nsp5).
Mpro cleaves the viral ‘polyproteins’ at a number of specific sites thereby generating a multi-subunit protein complex termed ‘viral replicase-transcriptase’. Because of its functional indispensability in viral replication, Mpro is an attractive drug target for the development of a treatment for COVID-19 and other Coronavirus infections,” said Dr. Slilaty.
https://www.sunshinebiopharma.com/sunshine-biopharma-files-a-patent-application-for-a-new-coronavirus-covid-19-treatment/
------------
About Essential Calcium Vitamin DTM --- Vitamin D ---
Sunshine Biopharma Receives Health Canada Approval for Essential Calcium-Vitamin DTM Supplement
Montreal, Quebec, Canada – (ACCESSWIRE) – Sunshine Biopharma, Inc. (OTC Markets: “SBFM”) today announced that it has received Health Canada approval for Essential CalciumVitamin DTM supplement, the second in a line of Essential Micronutrients Products that the Company is planning to launch. Health Canada issued NPN 80093432 through which it authorized Sunshine Biopharma to manufacture and sell a Calcium-Vitamin D supplement under the brand name Essential Calcium-Vitamin .
Essential Calcium-Vitamin DTM is a dietary supplement tablet that contains a balanced formula of Calcium and Vitamin D complex.
Vitamin D plays a major role in multiple biological functions, including regulating the concentration of calcium and phosphate, and promoting the healthy growth and remodeling of bone.
In addition, Vitamin D is involved in cell growth, neuromuscular and immune functions, and reduction of inflammation. Sunshine Biopharma anticipates that Essential Calcium-Vitamin DTM will be available on Amazon.ca in January 2020.
The Company’s first Essential Micronutrients Product, Essential 9TM , launched earlier this year is currently available in Canada on Amazon.ca and in the US on Amazon.com.
About Essential Calcium Vitamin DTM
Vitamin D is a group of steroid-like molecules responsible for increasing intestinal absorption of calcium, magnesium, and phosphate. They are also involved in multiple other biological
functions, including promoting the healthy growth and remodeling of bone, cell growth, neuromuscular and immune functions, and reduction of inflammation.
The most important compounds in this group are Vitamin D2 (ergocalciferol) and Vitamin D3 (cholecalciferol).
Sunshine Biopharma’s Essential Calcium-Vitamin DTM tablets contain both of these compounds as well as Calcium for optimum health benefits.
About Essential 9TM - Essential Amino Acids are 9 out of the 20 amino acids required for protein synthesis.
Proteins are involved in all body functions – From the musculature and immune system to hormones and neurotransmitters.
Like vitamins, Essential Amino Acids cannot be made by the human body and must be obtained through diet. Deficiency in one or more of the 9 Essential Amino Acids can lead to loss of muscle mass, fatigue, weight gain and reduced ability to build muscle mass in athletes.
Sunshine Biopharma’s Essential 9TM provides all 9 Essential Amino Acids in freeform and in the proportions recommended by Health Canada. Essential 9TM is suitable for everyone: vegans, athletes, seniors, dieters.
Essential 9tm is currently available on Amazon.ca and Amazon.com
https://www.sunshinebiopharma.com/sunshine-biopharma-receives-health-canada-approval-for-essential-calcium-vitamin-dtm-supplement/
$LWLG New Corporate Video
https://vimeo.com/432280150
$LWLG New Corporate Video
https://vimeo.com/432280150
That one shot up.. Started following your investment corner and the trends you follow, you've been right about MJ/CBD last few years.. just learning about that NRGU .. interesting.
..just got here myself.. good insight !!
Nice !!
it's at the top of the most read boards right now CYD$
..similar therapeutic companies went from .25 cents to 10 bucks.. it can happen.
$SBFM (COVID-19) Meet Dr. Steve Slilaty
Professor, Doctor, CEO, Visionary
Dr. Slilaty is an accomplished scientist and a highly skilled business executive.
He received his Bachelor of Science degree in Genetics and Biochemistry from Cornell University and his Ph.D. in Molecular Biology & Biochemistry from the University of Arizona.
Dr. Slilaty is a leader in the bioscience industry and is referenced in editorials, reviews and textbooks.
His extensive contributions to science included the discovery of a new class of enzymes (IUBMB Enzyme: EC 3.4.21.88) and the development of key technology for the Human Genome Project (TrueBlue Cloning System).
With a passion for medicine, he founded three biotech companies and took one public. The company he took public, Genomics One Corporation reached $1 billion market cap.
At Sunshine Biopharma Dr. Slilaty is working with the same determination as he pioneers a path towards the discovery of ground breaking drugs for the treatment of aggressive forms of cancer.
What is Adva-27a?
Our Flagship AntiCancer Drug
https://www.sunshinebiopharma.com/
Dr. Steve N. Slilaty, Ph.D. serves as a Chairman of the Board, President, Chief Executive Officer of Sunshine Biopharma, Inc., since October 15, 2009.
In addition, since February 2002, Dr. Slilaty has been President and Chief Scientific Officer of Advanomics Corporation, Montreal, Canada, a privately held company engaged in the research, development and commercialization of drugs for the treatment of various forms of cancer. Advanomics Corporation is the third in a line of biotechnology companies that Dr. Slilaty founded and managed through their early and mid-stages of development.
The first, Quantum Biotechnologies Inc. later known as Qbiogene Inc., was founded in 1991 and grew to over $60 million in annual sales. Today, Qbiogene is a member of a family of companies owned by MP Biomedicals, one of the international suppliers of biotechnology reagents with a catalogue containing over 55,000 products.
The second company which Dr. Slilaty founded, Genomics One Corporation, now known as Alert B&C Corporation, conducted an initial public offering (IPO) of its capital stock in 1999 and, on the basis of its ownership of
Dr. Slilaty’s patented TrueBlue® Technology, Genomics One became one of the handful of participants in the Human Genome Project. Formerly a research team leader of the Biotechnology Research Institute, a division of the National Research Council of Canada, Dr. Slilaty also served as a consultant in a management and advisory capacity for a Canadian biotechnology company between 1995 and 1997 during which time the company completed one of the biotechnology IPO‘s in Canada raising over $34 million.
Dr. Slilaty received his Ph.D degree from the University of Arizona in 1983 and a Bachelor of Science degree from Cornell University in 1976.
Adva-27a, Our Flagship Anticancer Drug
https://sunshinebiopharma.com/drugs-development.html
Generic Drugs - Coming Soon
SBI-Anastrozole for treatment of Breast Cancer
SBI-Letrozole for treatment of Breast Cancer
SBI-Bicalutamide treatment of Prostate Cancer
SBI-Finasteride for treatment of BPH (Benign Prostatic Hyperplasia)
https://sunshinebiopharma.com/drugs-market.html
$LWLG Investor Presentation
https://www.lightwavelogic.com/investors/
$LWLG Investor Presentation
https://www.lightwavelogic.com/investors/
"satirical" ..mmH ? Thanks
?? did the Company make the tweet ? .if not then no violation .. I don't think the s/p rise is related anyways.. it's been stair-stepping for days now.. ;)
I don't think so.. another mentioned it was tied to a clickbait link in a tweet.. doesn't matter Company moves stand on their own IMO
$SBFM (COVID-19 and Vitamin D) SUNSHINE BIOPHARMA FILES A PATENT APPLICATION FOR A NEW CORONAVIRUS COVID-19 TREATMENT
Montreal, Canada – (ACCESSWIRE) – Sunshine Biopharma Inc. (OTC Pink Sheets: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of aggressive forms of cancer today announced that it has filed a patent application in the United States for a new treatment for Coronavirus infections, including COVID-19.
Sunshine’s patent application covers composition subject matter pertaining to small molecules for inhibition of the main Coronavirus protease (Mpro), an enzyme that is essential for viral replication. The small molecules covered by the patent application were computer modelled and designed by Dr. Steve N. Slilaty, CEO of Sunshine Biopharma.
The patent application has a priority date of May 22, 2020.
“The causative agent of the current COVID-19 global pandemic is Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), one of several strains of Coronavirus capable of infecting humans and causing serious illness.
SARS-CoV-2 produces several functional proteins in infected human cells by cleaving them from two overlapping viral ‘polyproteins,’ pp1a and pp1ab. One of these functional proteins is a cysteine protease referred to as the main protease (Mpro, also called 3CLpro and nsp5).
Mpro cleaves the viral ‘polyproteins’ at a number of specific sites thereby generating a multi-subunit protein complex termed ‘viral replicase-transcriptase’. Because of its functional indispensability in viral replication, Mpro is an attractive drug target for the development of a treatment for COVID-19 and other Coronavirus infections,” said Dr. Slilaty.
https://www.sunshinebiopharma.com/sunshine-biopharma-files-a-patent-application-for-a-new-coronavirus-covid-19-treatment/
------------
About Essential Calcium Vitamin DTM --- Vitamin D ---
Sunshine Biopharma Receives Health Canada Approval for Essential Calcium-Vitamin DTM Supplement
Montreal, Quebec, Canada – (ACCESSWIRE) – Sunshine Biopharma, Inc. (OTC Markets: “SBFM”) today announced that it has received Health Canada approval for Essential CalciumVitamin DTM supplement, the second in a line of Essential Micronutrients Products that the Company is planning to launch. Health Canada issued NPN 80093432 through which it authorized Sunshine Biopharma to manufacture and sell a Calcium-Vitamin D supplement under the brand name Essential Calcium-Vitamin .
Essential Calcium-Vitamin DTM is a dietary supplement tablet that contains a balanced formula of Calcium and Vitamin D complex.
Vitamin D plays a major role in multiple biological functions, including regulating the concentration of calcium and phosphate, and promoting the healthy growth and remodeling of bone.
In addition, Vitamin D is involved in cell growth, neuromuscular and immune functions, and reduction of inflammation. Sunshine Biopharma anticipates that Essential Calcium-Vitamin DTM will be available on Amazon.ca in January 2020.
The Company’s first Essential Micronutrients Product, Essential 9TM , launched earlier this year is currently available in Canada on Amazon.ca and in the US on Amazon.com.
About Essential Calcium Vitamin DTM
Vitamin D is a group of steroid-like molecules responsible for increasing intestinal absorption of calcium, magnesium, and phosphate. They are also involved in multiple other biological
functions, including promoting the healthy growth and remodeling of bone, cell growth, neuromuscular and immune functions, and reduction of inflammation.
The most important compounds in this group are Vitamin D2 (ergocalciferol) and Vitamin D3 (cholecalciferol).
Sunshine Biopharma’s Essential Calcium-Vitamin DTM tablets contain both of these compounds as well as Calcium for optimum health benefits.
About Essential 9TM - Essential Amino Acids are 9 out of the 20 amino acids required for protein synthesis.
Proteins are involved in all body functions – From the musculature and immune system to hormones and neurotransmitters.
Like vitamins, Essential Amino Acids cannot be made by the human body and must be obtained through diet. Deficiency in one or more of the 9 Essential Amino Acids can lead to loss of muscle mass, fatigue, weight gain and reduced ability to build muscle mass in athletes.
Sunshine Biopharma’s Essential 9TM provides all 9 Essential Amino Acids in freeform and in the proportions recommended by Health Canada. Essential 9TM is suitable for everyone: vegans, athletes, seniors, dieters.
Essential 9tm is currently available on Amazon.ca and Amazon.com
https://www.sunshinebiopharma.com/sunshine-biopharma-receives-health-canada-approval-for-essential-calcium-vitamin-dtm-supplement/
$SBFM (COVID-19 and Vitamin D) SUNSHINE BIOPHARMA FILES A PATENT APPLICATION FOR A NEW CORONAVIRUS COVID-19 TREATMENT
Montreal, Canada – (ACCESSWIRE) – Sunshine Biopharma Inc. (OTC Pink Sheets: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of aggressive forms of cancer today announced that it has filed a patent application in the United States for a new treatment for Coronavirus infections, including COVID-19.
Sunshine’s patent application covers composition subject matter pertaining to small molecules for inhibition of the main Coronavirus protease (Mpro), an enzyme that is essential for viral replication. The small molecules covered by the patent application were computer modelled and designed by Dr. Steve N. Slilaty, CEO of Sunshine Biopharma.
The patent application has a priority date of May 22, 2020.
“The causative agent of the current COVID-19 global pandemic is Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), one of several strains of Coronavirus capable of infecting humans and causing serious illness.
SARS-CoV-2 produces several functional proteins in infected human cells by cleaving them from two overlapping viral ‘polyproteins,’ pp1a and pp1ab. One of these functional proteins is a cysteine protease referred to as the main protease (Mpro, also called 3CLpro and nsp5).
Mpro cleaves the viral ‘polyproteins’ at a number of specific sites thereby generating a multi-subunit protein complex termed ‘viral replicase-transcriptase’. Because of its functional indispensability in viral replication, Mpro is an attractive drug target for the development of a treatment for COVID-19 and other Coronavirus infections,” said Dr. Slilaty.
https://www.sunshinebiopharma.com/sunshine-biopharma-files-a-patent-application-for-a-new-coronavirus-covid-19-treatment/
------------
About Essential Calcium Vitamin DTM --- Vitamin D ---
Sunshine Biopharma Receives Health Canada Approval for Essential Calcium-Vitamin DTM Supplement
Montreal, Quebec, Canada – (ACCESSWIRE) – Sunshine Biopharma, Inc. (OTC Markets: “SBFM”) today announced that it has received Health Canada approval for Essential CalciumVitamin DTM supplement, the second in a line of Essential Micronutrients Products that the Company is planning to launch. Health Canada issued NPN 80093432 through which it authorized Sunshine Biopharma to manufacture and sell a Calcium-Vitamin D supplement under the brand name Essential Calcium-Vitamin .
Essential Calcium-Vitamin DTM is a dietary supplement tablet that contains a balanced formula of Calcium and Vitamin D complex.
Vitamin D plays a major role in multiple biological functions, including regulating the concentration of calcium and phosphate, and promoting the healthy growth and remodeling of bone.
In addition, Vitamin D is involved in cell growth, neuromuscular and immune functions, and reduction of inflammation. Sunshine Biopharma anticipates that Essential Calcium-Vitamin DTM will be available on Amazon.ca in January 2020.
The Company’s first Essential Micronutrients Product, Essential 9TM , launched earlier this year is currently available in Canada on Amazon.ca and in the US on Amazon.com.
About Essential Calcium Vitamin DTM
Vitamin D is a group of steroid-like molecules responsible for increasing intestinal absorption of calcium, magnesium, and phosphate. They are also involved in multiple other biological
functions, including promoting the healthy growth and remodeling of bone, cell growth, neuromuscular and immune functions, and reduction of inflammation.
The most important compounds in this group are Vitamin D2 (ergocalciferol) and Vitamin D3 (cholecalciferol).
Sunshine Biopharma’s Essential Calcium-Vitamin DTM tablets contain both of these compounds as well as Calcium for optimum health benefits.
About Essential 9TM - Essential Amino Acids are 9 out of the 20 amino acids required for protein synthesis.
Proteins are involved in all body functions – From the musculature and immune system to hormones and neurotransmitters.
Like vitamins, Essential Amino Acids cannot be made by the human body and must be obtained through diet. Deficiency in one or more of the 9 Essential Amino Acids can lead to loss of muscle mass, fatigue, weight gain and reduced ability to build muscle mass in athletes.
Sunshine Biopharma’s Essential 9TM provides all 9 Essential Amino Acids in freeform and in the proportions recommended by Health Canada. Essential 9TM is suitable for everyone: vegans, athletes, seniors, dieters.
Essential 9tm is currently available on Amazon.ca and Amazon.com
https://www.sunshinebiopharma.com/sunshine-biopharma-receives-health-canada-approval-for-essential-calcium-vitamin-dtm-supplement/
$SBFM SUNSHINE BIOPHARMA FILES A PATENT APPLICATION FOR A NEW CORONAVIRUS COVID-19 TREATMENT
Montreal, Canada – (ACCESSWIRE) – Sunshine Biopharma Inc. (OTC Pink Sheets: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of aggressive forms of cancer today announced that it has filed a patent application in the United States for a new treatment for Coronavirus infections, including COVID-19.
Sunshine’s patent application covers composition subject matter pertaining to small molecules for inhibition of the main Coronavirus protease (Mpro), an enzyme that is essential for viral replication. The small molecules covered by the patent application were computer modelled and designed by Dr. Steve N. Slilaty, CEO of Sunshine Biopharma.
The patent application has a priority date of May 22, 2020.
“The causative agent of the current COVID-19 global pandemic is Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), one of several strains of Coronavirus capable of infecting humans and causing serious illness.
SARS-CoV-2 produces several functional proteins in infected human cells by cleaving them from two overlapping viral ‘polyproteins,’ pp1a and pp1ab. One of these functional proteins is a cysteine protease referred to as the main protease (Mpro, also called 3CLpro and nsp5).
Mpro cleaves the viral ‘polyproteins’ at a number of specific sites thereby generating a multi-subunit protein complex termed ‘viral replicase-transcriptase’. Because of its functional indispensability in viral replication, Mpro is an attractive drug target for the development of a treatment for COVID-19 and other Coronavirus infections,” said Dr. Slilaty.
https://www.sunshinebiopharma.com/sunshine-biopharma-files-a-patent-application-for-a-new-coronavirus-covid-19-treatment/
------------
About Essential Calcium Vitamin DTM --- Vitamin D ---
Sunshine Biopharma Receives Health Canada Approval for Essential Calcium-Vitamin DTM Supplement
Montreal, Quebec, Canada – (ACCESSWIRE) – Sunshine Biopharma, Inc. (OTC Markets: “SBFM”) today announced that it has received Health Canada approval for Essential CalciumVitamin DTM supplement, the second in a line of Essential Micronutrients Products that the Company is planning to launch. Health Canada issued NPN 80093432 through which it authorized Sunshine Biopharma to manufacture and sell a Calcium-Vitamin D supplement under the brand name Essential Calcium-Vitamin .
Essential Calcium-Vitamin DTM is a dietary supplement tablet that contains a balanced formula of Calcium and Vitamin D complex.
Vitamin D plays a major role in multiple biological functions, including regulating the concentration of calcium and phosphate, and promoting the healthy growth and remodeling of bone.
In addition, Vitamin D is involved in cell growth, neuromuscular and immune functions, and reduction of inflammation. Sunshine Biopharma anticipates that Essential Calcium-Vitamin DTM will be available on Amazon.ca in January 2020.
The Company’s first Essential Micronutrients Product, Essential 9TM , launched earlier this year is currently available in Canada on Amazon.ca and in the US on Amazon.com.
About Essential Calcium Vitamin DTM
Vitamin D is a group of steroid-like molecules responsible for increasing intestinal absorption of calcium, magnesium, and phosphate. They are also involved in multiple other biological
functions, including promoting the healthy growth and remodeling of bone, cell growth, neuromuscular and immune functions, and reduction of inflammation.
The most important compounds in this group are Vitamin D2 (ergocalciferol) and Vitamin D3 (cholecalciferol).
Sunshine Biopharma’s Essential Calcium-Vitamin DTM tablets contain both of these compounds as well as Calcium for optimum health benefits.
About Essential 9TM - Essential Amino Acids are 9 out of the 20 amino acids required for protein synthesis.
Proteins are involved in all body functions – From the musculature and immune system to hormones and neurotransmitters.
Like vitamins, Essential Amino Acids cannot be made by the human body and must be obtained through diet. Deficiency in one or more of the 9 Essential Amino Acids can lead to loss of muscle mass, fatigue, weight gain and reduced ability to build muscle mass in athletes.
Sunshine Biopharma’s Essential 9TM provides all 9 Essential Amino Acids in freeform and in the proportions recommended by Health Canada. Essential 9TM is suitable for everyone: vegans, athletes, seniors, dieters.
Essential 9tm is currently available on Amazon.ca and Amazon.com
https://www.sunshinebiopharma.com/sunshine-biopharma-receives-health-canada-approval-for-essential-calcium-vitamin-dtm-supplement/
..had an order for .326 and took it down to watch.. glad I did.. only mentioned it because I saw it on the news.. I am watching !! also noticed a vitamin D news release on the sunshine site.. interesting that helps with Covid.. I also owned shares in this company for almost 20 years
I was going to buy this morning till I heard the news (below) but will pay attention because it's still early in the game and these first treatments are not proven long term / side effects ..etc... Sunshine Biopharma could have the goods ??
U.S. to pay Pfizer, BioNTech $1.95 billion for millions of COVID-19 vaccine doses https://reut.rs/2WMEMKb
$LWLG Lightwave Logic Announces Launch of New Corporate Website
ENGLEWOOD, CO / ACCESSWIRE / July 21, 2020 / Lightwave Logic, Inc.
(OTCQB:LWLG), a technology platform company leveraging its proprietary electro-optic polymers to transmit data at higher speeds with less power, today announced the official launch of its new corporate website www.lightwavelogic.com, reflecting ongoing efforts to provide up-to-date information for investors and potential strategic partners.
The new website has been designed to be more dynamic, user friendly and content rich - best showcasing the Company's proprietary electro-optic polymers and advanced chemistry expertise. The revamped website offers a clean, modern design integrated with helpful tools and investor relations resources, including a new corporate explainer video, to illustrate the target markets and advantages of Lightwave Logic's proprietary electro-optic polymers.
"We are excited to launch our revamped corporate and investor relations webpages ... https://www.lightwavelogic.com/
When I bought this stock in 2013 it was mainly speculative hope over things I didn't understand "I still don't (science stuff)" but here in 2020 we have a capable and fascinating team with not only a polymer to get the job done but several variants along with one of a kind testing equipment and the inhouse marketable vehicles to work with those polymers.. and they are being (( BETA ))tested.. Man.. we have come so far along.. I don't know .. I'm happy with my investment in Lightwave. they've come a long ways in a short time IMO
Irishbull I accept your opinion.. but I don't have a problem and I am not enabling anyone.. sorry.
Some interesting notes from Sleek :
A few things worth mentioning about the upcoming Phase Four Covid-19 Economic Stimulus Bill
All eyes in the MJ sector are focused on it due to the fact that the House’s version, the HEROES Act, includes the SAFE Banking Act, which would open up banking for both the MJ and Hemp industries
Eyeballs are potential investors for CBD stocks, especially eyeballs that already feel comfortable with the idea of investing in cannabis
Even though a standalone CBD bill would have been more preferable due to the greater singular spotlight that creates, the SAFE Banking Act included in the House’s Phase Four bill creating an audience of MJ investors is a nice consolation prize
Now there is nothing definite about what’s going to happen
This is not an absolute lock to happen
History has taught us that many times since Hemp Legalization was passed in December 2018
We have been bombarded with negative catalysts, many of which were strange and unpredictable:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156295678
However, it’s now been 19 months since Hemp Legalization has passed, and the upcoming legislation is the single best opportunity we have seen thus far to solve the CBD conundrum
There are certainly a number of positive signs heading into this legislative opportunity worthy of mentioning...
The House introduced the subject of federal cannabis legislation, providing a nice segue into Hemp-CBD legislation
Jonathan Miller is dropping hints:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156296047
In fact, a cadre of the usual suspects have been leaving breadcrumbs in for us to follow in 2020:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156595540
The economy is in shambles
It’s an election year where Trump and Mitch want to maximize the turnout of rural conservative districts where farmers reside
Mitch also has some pride at stake as he legalized hemp and then “left the industry hanging”
New FDA Commissioner Dr. Hahn from Texas is as good as it gets for the CBD industry
Trump is losing the election right now and I expect him to come out swinging with this legislation — his executive order to deregulate due to the economic emergency also plays very nicely into the CBD Conundrum, which is largely an issue of regulation
Getting back to those MJ eyeballs for a second...
If Mitch comes through for all of us and Pure CBD Beverages and Supplements are federally legalized, for the very first time in American history Hemp-derived Pure CBD products will be fully legal with no strings attached and capable of being sold in national chains in all 50 states, whereas MJ products will continue to be shackled by their federal illegality in a scattered state-by-state patchwork economy sold only in specialized dispensaries
The separation of MJ and CBD stocks is long overdue and Hemp-CBD stocks would rightfully deserve to become the new darling of cannabis investors
Sleek
SLEEKSCAPE’S GRAND SALAMI FOR 2020 HEMP & CBD MANIA -- PART II
https://investorshub.advfn.com/$LEEK$CAPE’S-2020-HEMP-CBD-&-MARIJUANA-MANIA-GRAND-SALAMI-PART-II-31243/
------------
Mr. Miller joins Mr. Brindisi
Both very smart guys
Putting their stamp on a truly national CBD economy right before they think it can actually happen
Excellent article, Jonathan:
How To Boost Hemp Farmers During The Pandemic Without A Taxpayer Bailout: Regulate CBD
July 17, 2020
Unfortunately, public statements by FDA officials arguing that it is illegal to sell ingestible hemp-derived CBD products have taken a toll on the industry. While the agency has primarily taken action against companies that have made improper disease claims, and while FDA officials have announced that they are investigating a regulatory pathway for CBD products, CBD commerce and investment have been chilled due to the absence of federal regulation, impairing economic opportunity for farmers and small businesses.
Read the full article here:
https://www.benzinga.com/markets/cannabis/20/07/16671873/how-to-boost-hemp-farmers-during-the-pandemic-without-a-taxpayer-bailout-regulate-cbd
Sleek
-----------
Why CBD Legalization and The CBD Mania Are Inevitable
Ever since receiving our first dose of preliminary confirmation from Jonathan Miller on April 1st signaling that 2020 may finally bring us to the finish line of this long and arduous journey, I’ve spent a lot of time thinking about what it might be like on the other side of this battle
US Hemp Roundtable
@HempRoundtable
This will only change when the @FDA provides a regulatory path for the legal sale of CBD, something that they have been suggesting since 12/18 when the 2018 Farm Bill was signed. It has been taking them a long time, too long for much of the industry and many in Congress.
We are working with our supporters in Congress to pass legislation to force the @FDA to act, and there is some hope that such language may be added to a future stimulus bill.
5:38 PM · Apr 1, 2020
https://mobile.twitter.com/HempRoundtable/status/1245465601658826759
I’m a pretty competitive person and I tend to gravitate towards challenges
Trying to pinpoint the start date of this long-awaited CBD Mania has been a very serious challenge
It’s been significantly more difficult than I anticipated
Manias are a catalyst-driven phenomenon
They always have been and they always will be
They certainly don’t happen by accident
They require a highly significant positive catalyst
The past few cannabis manias we’ve witnessed (in America) have all shared one thing in common — they’ve had an actual calendar date directly attached to an enormous manic catalyst that can be summed up in 1 word
2014 — January 1 — “Colorado”
2016 — November 8 — “Election”
2018 — January 1 — “California”
2020 — June/July 2020 ??? — “CBD”
Despite the existence of these dated event-based catalysts in 2014, 2016 and 2018, all 3 of these manias were not predicted by the market
The cannabis sector before these manias began was marked by bottoming stock prices, disinterest and low volumes
There was no warning signal given
The manias all started suddenly and violently
There has been one exception to the dated catalyst paradigm
So we have seen one cannabis mania that had no calendar date attached and no enormous scheduled catalyst
That was the October 30th, 2017 Canadian Recreational MJ “Legalization” Mania, marked by a spontaneous overnight catalyst that signaled confidence in the future legalization of Recreational MJ via legislation in Canada, when Constellation Brands took a 10% stake in Canopy Growth — the mania in Canada began suddenly and violently the very next day
That’s been the only “legalization” mania we have seen in the cannabis sector thus far
— — —
Hemp Legalization was an absolute requirement in order to achieve an environment in the cannabis sector readily conducive for a CBD Mania
Many believed that Hemp Legalization was virtually synonymous with CBD Legalization, and even though there were some questions about how the FDA would regulate CBD, because the driving reason behind Hemp’s legalization was CBD itself, there was an expectation that the FDA would employ a hands-off strategy while they worked on creating regulations for CBD
In this setting, mania formation around the CBD sector was a relatively logical outcome
The difficulty came in pinpointing the specific nature and date of the manic catalyst
Would Coca Cola confirm the rumors and publicly announce their interest in developing CBD Beverages?
Would Starbucks announce an interest in serving CBD beverages in their stores?
Would we see a mimicry of Canada in 2017, where a large beverage behemoth takes a stake in a huge CBD company, with Mile High Labs or Charlotte’s Web playing the role of Canopy Growth?
With no specific dated catalyst on the horizon, the projected CBD Mania felt most similar to The 2017 Canadian Rec MJ Mania, more likely to be triggered by a spontaneous catalyst like the ones above
— — —
Ever since Mitch McConnell singlehandedly pushed Hemp Legalization inside of The 2018 Farm Bill over the finish line on December 20th 2018, we’ve seen some small to medium-sized victories — USDA’s rapid creation of regs, USPS and FAA legalizing interstate mailing of and air travel with CBD products, the FDA not shutting down CBD stores or confiscating CBD products despite their proclamations that these products were federally illegal, and the confirmation of outsider Texan Dr. Hahn as the new FDA Commissioner
However, along with this handful of smaller victories, the time since Mitch’s legislative victory at the end of 2018 has been largely marked by a succession of negative catalysts that have greatly stifled the excitement in the CBD sector and in several instances, acted directly to delay any CBD Mania
Some of these negative catalysts have been spontaneous ones incapable of being predicted — those are the ones that hit the hardest, the real emotional downers — the vaping crisis, the FDA warning letter, the coronavirus
For some, the road has been too bumpy, too rough, too disappointing
Many have thrown in the towel, figuring that maybe this mania just isn’t meant to be
Even though I may disagree with that thought process, I can certainly understand the sentiment behind it
This has been a really tough trip
The series of negative catalysts that have hit us thus far have been undeniably devastating — though I consider myself generally optimistic and emotionally resilient, at times I’ve been left feeling like I’m living in the CBD investment version of The Twilight Zone — there’s a surreal quality to it all
All that being said, despite the improbable run of negative catalysts that have bombarded us, after discounting their emotional impacts on my own psyche as an investor, none of them have changed my mind on the inevitability of the CBD Mania, simply because all of the conditions necessary for mania development remain firmly in place
Cannabis manias are never sparked by investors who are already invested in the sector, which has always been in a beaten-down state before the mania strikes — but by a new wave of investors who are attracted to the sector by the manic catalyst — these investors haven’t paid their dues like we have — but that’s okay, because they will become the spark that lights the flame in the CBD sector, so we should be grateful for their arrival
Now let’s take a moment to look back at what’s transpired before we look ahead to the future
After Mitch singlehandedly pushed federal hemp legalization across the finish line in Congress in December 2018, and before we were hit over the head with our trio of spontaneous consecutive negative catalysts not directly related to the CBD sector — the vaping crisis, impeachment, and the coronavirus — there was the government shutdown, the false but repetitive media headlines of an FDA crackdown, and the unexpected departure of FDA Commissioner Gottlieb with the subsequent installation of Sharpless as the interim FDA Commissioner
The final pair of negative catalysts we’ve endured include the alarmist FDA Warning Letter and the long delay in the deliverance of the FDA Report On CBD to Congress
That’s 8 negative catalysts in 15 months
No wonder it feels like we’ve been put through the wringer
This slew of negative catalysts has changed the mechanistics surrounding the initiation of any theoretical CBD Mania — the idea of a spontaneous catalyst triggering the mania was killed off by the FDA Crackdown Fallacy peddled incessantly by the national media last year — as a result, the most rational formula for the development of a CBD Mania in 2020 involves legislation and/or regulation, CBD Legalization from Congress and/or FDA Enforcement Discretion, both of which would result in national sales of CBD products
Even though this string of negative catalysts has changed the most likely formula for the development of a CBD Mania and has resulted in successively higher doses of emotional pain while we wait for Congress and the FDA to get their $hit together, if we look at all 8 of these negative catalysts and their outcomes through an objective lens, they haven’t changed the inevitability of the CBD Mania
#1 Government Shutdown — Jan 2019
Inability to pass annual budget led to a 5-week government shutdown at the very start of 2019
Lost momentum from Hemp Legalization in December 2018
Emotional Pain Rating: 3
End Result: Doesn’t change inevitability of CBD Mania
#2 False and Repetitive Media Headlines Stoking Fear Of FDA Crackdown On CBD — Feb/Mar/April 2019
CBD Products have been out there for nearly 18 months since FDA took over regulatory authority in January 2019, and not only haven’t they removed any products from shelves, but since Dr. Hahn took over the FDA in December 2019 he has made it very clear that there isn’t going to be any crackdown
Emotional Pain Rating: 7
End Result: Doesn’t change inevitability of CBD Mania
#3 Sudden Departure of FDA Commish Dr. Gottlieb and Arrival of Interim FDA Commish Dr. Sharpless — April/May/June/July/August/Sept/Oct/Nov 2019
This left us with lame-duck interim Commissioner Dr. Sharpless, who literally did nothing to advance CBD regulations during his tenure, which lasted through most of 2019 — this actually turned out to be the predominant source of the inaction and delay in the FDA’s development of regulations for CBD in 2019
If Dr. Gottlieb never left the FDA, we very well could have seen the CBD Mania occur 12 months earlier, in the Summer/Fall of 2019:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150282255
Emotional Pain Rating: 8
End Result: Doesn’t change inevitability of CBD Mania
#4 The Vaping Crisis — Aug/Sept/Oct/Nov 2019
Thousands of Americans mysteriously developed severe lung injuries as a result of using vaping devices, which were left completely unregulated by the FDA
This really stung because CBD products had nothing to do with the vaping crisis and were simply an innocent bystander purely due to being in the same unregulated category as vaping products — the real culprit didn’t even turn out to be vaping or CBD, but Vitamin E Acetate found in black market THC Oil vapes
This led to Congressional hearings where Congress berated the FDA for months, because the former FDA Commissioner (Dr. Gottlieb) had spoken very strongly and openly about wanting to regulate the vaping industry and ban certain vaping products, but the FDA never followed through on it
The FDA found itself in an indefensible position and bore the brunt of the blame for this public health crisis, which claimed the lives of 68 people and resulted in over 2500 lung injuries
I’m convinced that had we not experienced the vaping crisis, we wouldn’t have experienced the FDA’s reaction to the vaping crisis, which turned out to be the next negative catalyst
Emotional Pain Rating: 9
End Result: Doesn’t change inevitability of CBD Mania
#5 The FDA Warning Letter About CBD Products — Nov 2019
In a very uncharacteristic fashion, seemingly in response to the vaping crisis, the FDA published an overly alarmist cover-your-ass warning letter about CBD products, telling Americans that they could be injured by using unregulated CBD products
The timing of this warning letter was very unfortunate because the fear from the vaping crisis had receded markedly by this point, and Jonathan Miller had stated 3 weeks earlier that the legislative plan was to legalize CBD in Dietary Supplements and Foods in the end of year appropriations bill
Likely as a direct result of the FDA Warning Letter, Mitch decided to pull back on legalizing CBD products in the year-end funding bill
So had the vaping crisis never occurred, it is very doubtful that this FDA Warning Letter on CBD would have been published, and we very well could have seen our CBD Legalization Mania begin in December 2019
Emotional Pain Rating: 9.5
End Result: Doesn’t change inevitability of CBD Mania
#6 House Impeachment and Senate Trial — Dec 2019/Jan 2020
Senator Crapo had spoken about moving the Senate’s version of The SAFE Banking Act out of his Senate Banking Committee and onto the Senate Floor in January 2020
The SAFE Banking Act was thought to be the standalone legislative vehicle to which CBD Legalization and Enforcement Discretion could be attached
The CBD Mania was therefore slated to begin in the Winter of 2020, but the impeachment postponed this possibility
Emotional Pain Rating: 7
End Result: Doesn’t change inevitability of CBD Mania
#7 The Novel Coronavirus — Feb/March/April/May/June 2020
As if we haven’t already suffered an unbelievable string of spontaneous negative catalysts since Mitch passed federal hemp legalization through Congress in December 2018, a once-in-a-century pandemic strikes as the Senate was getting ready to start moving legislation again after the conclusion of the impeachment trial
You couldn’t make up another spontaneous negative catalyst more horrific than this one
I consider myself very fortunate as I haven’t lost anybody close to me thus far, but one of my family members has lost a close friend and a good friend of mine has lost a co-worker
To anybody who hasn’t been as fortunate, my condolences go out to you
@#$& you Covid-19
Emotional Pain Rating: 10
End Result: Doesn’t change inevitability of CBD Mania
#8 Long delay of 7-8 months in the deliverance of the FDA Report On CBD to Congress — March 2020
Congress was purportedly waiting for the FDA Report on CBD to be sent to them before taking up any legislation on CBD
It was originally said to be published by mid-summer 2019
It didn’t arrive until March 5th 2020
Emotional Pain Rating: 8
End Result: Doesn’t change inevitability of CBD Mania
So what’s the upshot of running through this gauntlet of negative catalysts, none of which served to change the inevitability of the CBD Mania?
If none of these roadblocks, booby traps, sneak attacks and nuclear bombs have been able to stop the CBD Legalization Movement, then it’s pretty doubtful at this point that anything has the power to stop it
Some things are just meant to happen
Destiny is the end of a journey whose conclusion is so highly probable that despite whatever obstacles may arise along the way, any delay in getting there is only a temporary phenomenon
Sleek
$MSTO Stacking them Cars, Houses and Gold !!!
..nice to buy in the .60's and sell 1.30-150's .. nothing wrong with that.. I suspect they believed they were going to get a deal earlier.. and it was easier to stick w/LPC.. I don't believe there's something seriously wrong maybe it's Corporate envy or the big 3 just not letting the little guy w/the 100 MPG fuel injection get his shot. (but the times will force a move IMO)
..if a deal does come soon all these LPC worries will go away.. hope you have a bunch for when this goes to $60.oo :)